Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$580,000 |
 |
MedtronicMDT |
-$110,000 |
 |
Edwards LifesciencesEW |
$49,000 |
 |
Intuitive SurgicalISRG |
$16,000 |
 |
MedpaceMEDP |
-$32,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul | Sep 22, 2025 | Buy | $1K - $15K |
| Michael McCaul | Jun 16, 2025 | Sell | $15K - $50K |
| Michael McCaul | Jun 2, 2025 | Buy | $15K - $50K |
| Rob Bresnahan | May 15, 2025 | Buy | $1K - $15K |
| Michael McCaul | Apr 8, 2025 | Buy | $50K - $100K |
| Rob Bresnahan | Apr 8, 2025 | Sell | $1K - $15K |
| Jefferson Shreve | Apr 7, 2025 | Sell | $15K - $50K |
| Michael McCaul | Mar 13, 2025 | Buy | $15K - $50K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $1K - $15K |
| Kevin Hern | Dec 31, 2024 | Sell | $50K - $100K |
| Ro Khanna | Sep 9, 2024 | Buy | $1K - $15K |
FAQ - Congress Trading
Michael McCaul purchased Dexcom shares most recently on September 22, 2025.
Michael McCaul has bought the most DXCM stock in the last 2 years, with an estimated value of $150,000.
Kevin Hern has sold the most DXCM stock in the last 2 years, with an estimated value of $75,000.
According to our estimates, the net value of trades by US politicians for Dexcom in the last 2 years is positive, amounting to $24,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Dexcom have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
